A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments. They said two of the drugs, pralatrexate and azithromycin, successfully inhibited replication of the virus, and further lab experiments showed that pralatrexate more strongly inhibited viral …
Researchers have developed a new 3D-printed device that could help reduce side effects of chemotherapy such as hair loss, nausea and heart failure. But if excess chemotherapy drugs could be removed from a patient's bloodstream after they have worked, they might reduce the side effects. But using the device, excess doxorubicin can be filtered out from the blood at locations …
)
